Gerald W. McLaughlin Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Gerald W. McLaughlin.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Gerald W. McLaughlin. Gerald W. McLaughlin is a Director in AYTU BIOPHARMA, INC ($AYTU) and an Chief Executive Officer in Neos Therapeutics, Inc. ($NEOS) and a Director in Nemus Bioscience, Inc. ($NMUS).
Address: 227 WASHINGTON STREET, SUITE 200 CONSHOHOCKEN 19428 PA
Companies in which Gerald W. McLaughlin is an Insider
AYTU BIOPHARMA, INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Gerald W. McLaughlin: Director
Holdings: 31,401 shares
Current Value: $27,947
Latest Transaction: Apr 12 2021
$AYTU Market Capitalization: $11.06M
$AYTU Previous Close: $0.89
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Neos Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Gerald W. McLaughlin: Chief Executive Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Mar 19 2021
$NEOS Market Capitalization: $81.10M
$NEOS Previous Close: $5.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Skye Bioscience, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Gerald W. McLaughlin: Director
Holdings: 61,250 shares
Current Value: $28,175
Latest Transaction: Oct 22 2015
$NMUS Market Capitalization: $8.53M
$NMUS Previous Close: $0.46
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Gerald W. McLaughlin
Sentiment: All, AYTU, NEOS, NMUS
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 12 2021 | AYTU | AYTU BIOPHARMA, IN ... | McLaughlin Gerald W. | Director | Grant | A | 0.00 | 6,500 | 0 | 31,401 | 24.9 K to 31.4 K (+26.10 %) |
| Mar 19 2021 | NEOS | Neos Therapeutics, ... | McLaughlin Gerald W. | Chief Executive Off ... | Option Exercise | D | 2.31 | 65,447 | 151,183 | 0 | |
| Mar 19 2021 | NEOS | Neos Therapeutics, ... | McLaughlin Gerald W. | Chief Executive Off ... | Option Exercise | D | 5.55 | 100,000 | 555,000 | 0 | |
| Mar 19 2021 | NEOS | Neos Therapeutics, ... | McLaughlin Gerald W. | Chief Executive Off ... | Option Exercise | D | 1.49 | 395,000 | 588,550 | 0 | |
| Mar 19 2021 | NEOS | Neos Therapeutics, ... | McLaughlin Gerald W. | Chief Executive Off ... | Option Exercise | D | 2.31 | 392,688 | 907,109 | 0 | |
| Mar 19 2021 | NEOS | Neos Therapeutics, ... | McLaughlin Gerald W. | Chief Executive Off ... | Option Exercise | D | 6.20 | 600,000 | 3,720,000 | 0 | |
| Mar 19 2021 | NEOS | Neos Therapeutics, ... | McLaughlin Gerald W. | Chief Executive Off ... | Sell | D | 0.00 | 270,171 | 0 | 0 | 270.2 K to 0 (-100.00 %) |